| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.330 | 43.904 | 47.192 | 61.478 | 28.967 | 38.733 | 52.659 | - | - | - |
| Total Income - EUR | 8.330 | 43.904 | 47.192 | 61.478 | 28.967 | 38.733 | 52.659 | - | - | - |
| Total Expenses - EUR | 0 | 111 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Gross Profit/Loss - EUR | 8.330 | 43.793 | 47.192 | 61.478 | 28.967 | 38.733 | 52.659 | - | - | - |
| Net Profit/Loss - EUR | 8.080 | 42.609 | 45.776 | 59.633 | 28.098 | 37.571 | 51.079 | - | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
Check the financial reports for the company - Medix Il Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Current Assets | 8.375 | 51.635 | 97.953 | 154.214 | 180.152 | 215.470 | 263.432 | - | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Receivables | 45 | 39.515 | 86.039 | 145.937 | 172.036 | 207.508 | 255.646 | - | - | - |
| Cash | 8.330 | 12.120 | 11.915 | 8.277 | 8.116 | 7.963 | 7.786 | - | - | - |
| Shareholders Funds | 8.125 | 50.651 | 95.570 | 153.450 | 178.575 | 212.761 | 259.122 | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | - | - | - |
| Debts | 250 | 984 | 2.383 | 765 | 1.577 | 2.709 | 4.309 | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8560 - 8560" | |||||||||
| CAEN Financial Year |
8560
|
|||||||||
Comments - Medix Il Srl